The second Presidential Symposium of the 2025 World Conference on Lung Cancer (WCLC) will take place at 8:15 Central European Summer Time (CEST) today, Monday, September 8, in the Plenary Hall. While the first Presidential Symposium focused on targeted therapies, today’s symposium will span a range of topics in thoracic oncology.
“The second [symposium] will offer a global focus on the different disciplines involved in thoracic oncology,” said outgoing IASLC President Paul E. Van Schil, MD, PhD, who is Professor of Thoracic and Vascular Surgery, Antwerp University Faculty of Medicine. “We have outstanding abstracts on new developments in lung cancer and treatment.”
Incoming IASLC President Caicun Zhou, MD, PhD, will chair the session before officially beginning his term as president during the IASLC Business Meeting tomorrow, Monday, September 8.
Presidential Symposium 2 with Lectureship Award Presentations
8:15 CEST, Monday, September 8 • Plenary Hall
The second Presidential Symposium will explore a range of topics in thoracic oncology. The session will also feature the presentation of the Tsuguo Naruke Lectureship Award for Surgery and the Heine H. Hansen Lectureship Award for Small Cell Lung Cancer. LEARN MORE
The second Presidential Symposium will feature presentations on novel multimodality approaches for unresectable stage III non-small cell lung cancer (NSCLC) and a comparison of hypofractionated versus conventional radiotherapy for limited-stage small-cell lung cancer (LS-SCLC).
The symposium will also present data from:
- The randomized, phase III NADIM ADJUVANT trial exploring adjuvant chemotherapy versus chemo-immunotherapy for R0 stage IB-IIIA NSCLC
- Survival outcomes of VATS compared with open lobectomy for lung cancer
- A multi-center cohort study analyzing 74 versus 80 as the upper age limit for lung cancer screening
- Spread through air spaces (STAS) and patient outcomes from the phase III JCOG0802 trial of segmentectomy versus lobectomy in NSCLC
Leaders in thoracic oncology will be recognized during the session with the presentation of the Tsuguo Naruke Lectureship Award for Surgery and the Heine H. Hansen Lectureship Award for Small Cell Lung Cancer. The session will conclude with addresses from Dr. Van Schil and Dr. Zhou.
